These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
589 related articles for article (PubMed ID: 11807828)
21. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721 [TBL] [Abstract][Full Text] [Related]
22. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. Takahashi T; Yamaguchi S; Chida K; Shibuya M EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210 [TBL] [Abstract][Full Text] [Related]
23. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function. Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244 [TBL] [Abstract][Full Text] [Related]
24. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling. Giorgetti-Peraldi S; Murdaca J; Mas JC; Van Obberghen E Oncogene; 2001 Jul; 20(30):3959-68. PubMed ID: 11494124 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library. Zhu Z; Rockwell P; Lu D; Kotanides H; Pytowski B; Hicklin DJ; Bohlen P; Witte L Cancer Res; 1998 Aug; 58(15):3209-14. PubMed ID: 9699643 [TBL] [Abstract][Full Text] [Related]
26. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990 [TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Yamagishi S; Yonekura H; Yamamoto Y; Fujimori H; Sakurai S; Tanaka N; Yamamoto H Lab Invest; 1999 Apr; 79(4):501-9. PubMed ID: 10212003 [TBL] [Abstract][Full Text] [Related]
28. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489 [TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. Maity A; Pore N; Lee J; Solomon D; O'Rourke DM Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786 [TBL] [Abstract][Full Text] [Related]
30. 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Suzuma I; Mandai M; Takagi H; Suzuma K; Otani A; Oh H; Kobayashi K; Honda Y Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2122-9. PubMed ID: 10440269 [TBL] [Abstract][Full Text] [Related]
31. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. Barleon B; Hauser S; Schöllmann C; Weindel K; Marmé D; Yayon A; Weich HA J Cell Biochem; 1994 Jan; 54(1):56-66. PubMed ID: 8126087 [TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. Shen BQ; Lee DY; Zioncheck TF J Biol Chem; 1999 Nov; 274(46):33057-63. PubMed ID: 10551875 [TBL] [Abstract][Full Text] [Related]
33. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells. Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278 [TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. Strizzi L; Catalano A; Vianale G; Orecchia S; Casalini A; Tassi G; Puntoni R; Mutti L; Procopio A J Pathol; 2001 Apr; 193(4):468-75. PubMed ID: 11276005 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of hepatic stellate cell contraction during activation in vitro by vascular endothelial growth factor in association with upregulation of FLT tyrosine kinase receptor family, FLT-1. Mashiba S; Mochida S; Ishikawa K; Inao M; Matsui A; Ohno A; Ikeda H; Nagoshi S; Shibuya M; Fujiwara K Biochem Biophys Res Commun; 1999 May; 258(3):674-8. PubMed ID: 10329444 [TBL] [Abstract][Full Text] [Related]
39. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725 [TBL] [Abstract][Full Text] [Related]
40. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. Waltenberger J; Mayr U; Frank H; Hombach V J Mol Cell Cardiol; 1996 Jul; 28(7):1523-9. PubMed ID: 8841939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]